Phase II trial of S-1 with concurrent radiotherapy in T2N0M0 laryngeal, mesopharynx, hypopharynx cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 27 Jan 2010 Status changed from not yet recruiting to recruiting University Hospital Medical Information Network - Japan.
- 25 Jul 2009 New trial record